The Translational Initiative to Map Epigenetics in Aging (TIME-A)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

25000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-08

Study Completion Date

2033-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Translational Initiative to Map Epigenetics in Aging (TIME-A) study aims to advance our understanding of the connections between epigenetics, lifestyle, demographics, and health and aging.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

NCT06953180

Cardiovascular Diseases (CVD) Type 2 Diabetes Chronic Respiratory Diseases +2 more

RECRUITING

A Model for Healthy Aging: Moscow Centenarians (AGE-100)

NCT02876809

Aging

COMPLETED

Aging and Frailty Study

NCT05268991

Effects of Chemotherapy Aging Frailty

COMPLETED

National Survey to Understand Ethical, Legal and Social Issues in Communicating to the Public About Epigenetics

NCT07020234

Healthy

COMPLETED NA

Supporting Healthy Aging by Peer Education and Support

NCT02745275

Health Behavior Ageing

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

TIME-A is a longitudinal research initiative. Anyone who has ever taken an Index test registered through Elysium Health is eligible to participate. Participation involves answering questions that will be administered via a survey format. Research participants' survey responses will be combined with their epigenetic Index data with the primary aim of identifying the contributions of 1) environmental and lifestyle factors, 2) general health, and 3) medical history, on biological age. Exploratory aims include the development of epigenetic signatures that are predictive of health status, and exploring the relationship between epigenetically-derived health phenotypes and biological age. These findings will lay the foundation for personalized health recommendations using Index (including, but not limited to: workout routines, diets, supplement regimens, medications, lifestyle changes).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Biological Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TIME-A

Group will complete periodic surveys

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All adults aged 18 and above
* Have registered at least one Index kit via the Elysium Health website
* Able and willing to provide digital consent to the Research Consent Form, and the TIME-A Research Subject Consent Form